Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans-Reference-Cited by-同舟云学术

Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans

Published:2013-03-05 Issue:3 Volume:8 Page:e57672
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Ying-Lien,Lehman Virginia N.,Averette Anna F.,Perfect John R.,Heitman Joseph

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Calderone RA (2002) Candida and Candidiasis (Chapter 1: Introduction and historical perspectives): p.3–13. American Society for Microbiology, Washington, DC.

2. Hidden killers: human fungal infections;GD Brown;Sci Transl Med,2012

3. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality;M Morrell;Antimicrob Agents Chemother,2005

4. Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring;MJ Dolton;Antimicrob Agents Chemother,2012

5. Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report;AL Ngai;Int J Antimicrob Agents,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAF to the rescue! Potential and challenges of combination antifungal therapy for reducing morbidity and mortality in hospitalized patients with serious fungal infections;2024-07-11

2. Development of a yeast cell based method for efficient screening of high yield tacrolimus production strain;3 Biotech;2023-12-31

3. Simultaneous Determination of Posaconazole and Hemp Seed Oil in Nanomicelles through RP-HPLC via a Quality-by-Design Approach;ACS Omega;2023-08-11

4. Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy;Annals of Pharmacotherapy;2023-06-05

5. Atazanavir Resensitizes Candida auris to Azoles;Antimicrobial Agents and Chemotherapy;2023-05-17